Predicted miRNAs indeed target 3′UTR of F8-mRNA. (A) Relative luciferase activity in HEK-293T and Hep-G2 cells transfected with luciferase reporter plasmid pEZX-MT05 and miRNA expression vectors (pEZX-MR04), for miR-144, miR-19b and miR-186 and scrambled miRNA as control (SC) (Mean ± SEM for HEK293: SC = 0.993 ± 0.024, N = 15; miR-144 = 0.977 ± 0.017, N = 6; miR-19b = 0.7656 ± 0.017, N = 6; miR-186 = 0.816 ± 0.035, N = 15 and for Hep-G2: SC = 0.999 ± 0.078, N = 6; miR-144 = 0.962 ± 0.013, N = 6; miR-19b = 0.897 ± 0.032, N = 6; miR-186 = 0.782 ± 0.055, N = 9). (B) QPCR analysis to determine overexpression level of miRNAs 72 h after transfection (Mean ± SEM for HEK-293T: SC = 1.020 ± 0.023, N = 4; miR-144 = 946505 ± 40246, N = 3; miR-19b = 320.2 ± 31.61, N = 3; miR-186 = 17.39 ± 1.91, N = 6 and for Hep-G2: SC = 1.001 ± 0.039, N = 4; miR-144 = 5358 ± 208.3, N = 3; miR-19b = 124.5 ± 8.98, N = 3; miR-186 = 4.392 ± 0.257, N = 8) and (C) expression of endogenous miRNAs: miR-144, miR-19b and miR-186 in whole blood (WB from two healthy donors), HEK-293T, liver cell lines: Hep-G2, Huh-7, and HeLa, relative to LCL cells (Mean ± SEM for miR-144: LCL = 1.281 ± 0.287, N = 6; WB = 386,400 ± 84274, N = 6; HEK-293 = 1.100 ± 0.057, N = 3; Hep-G2 = 25.39 ± 2.53, N = 3; Huh-7 = 97.2 ± 6.73, N = 3 and HeLa = 23.94 ± 4.11, N = 3; for miR-19b: LCL = 1.020 ± 0.089, N = 6; WB = 4.303 ± 1.082, N = 6; HEK-293 = 63.34 ± 5.204, N = 3; Hep-G2 = 7.820 ± 1.190, N = 3; Huh-7 = 0.985 ± 0.005, N = 3 and HeLa = 7.225 ± 0.935, N = 3; and for miR-186: LCL = 1.015 ± 0.075, N = 6; WB = 235.9 ± 28.74, N = 6; HEK-293 = 49.02 ± 4.074, N = 3; Hep-G2 = 36.14 ± 1.414, N = 3; Huh-7 = 3.336 ± 0.362, N = 3; and HeLa = 36.03 ± 0.81, N = 3). *P < 0.05; **P < 0.01; ***P < 0.001.